Treace Medical Concepts, Inc. TMCI
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -3.95% | -1.66% | 1.59% | 7.90% | 7.67% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.95% | -1.66% | 1.59% | 7.90% | 7.67% |
| Cost of Revenue | -0.73% | 0.98% | 4.49% | 12.00% | 10.74% |
| Gross Profit | -4.75% | -2.31% | 0.88% | 6.91% | 6.93% |
| SG&A Expenses | -0.15% | 0.04% | -0.36% | -2.40% | -4.01% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.38% | -0.40% | 0.30% | 0.45% | -0.70% |
| Operating Income | -10.08% | -4.66% | 4.55% | 23.82% | 26.26% |
| Income Before Tax | -21.01% | -15.20% | -5.85% | 18.55% | 22.77% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.01% | -15.20% | -5.85% | 18.55% | 22.77% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.01% | -15.20% | -5.85% | 18.55% | 22.77% |
| EBIT | -10.08% | -4.66% | 4.55% | 23.82% | 26.26% |
| EBITDA | -14.92% | -5.29% | 9.82% | 29.98% | 32.07% |
| EPS Basic | -17.91% | -12.60% | -3.91% | 19.93% | 23.80% |
| Normalized Basic EPS | -10.43% | -5.72% | 2.62% | 21.52% | 23.79% |
| EPS Diluted | -17.52% | -12.26% | -3.61% | 19.67% | 23.55% |
| Normalized Diluted EPS | -10.43% | -5.72% | 2.62% | 21.52% | 23.79% |
| Average Basic Shares Outstanding | 2.71% | 2.27% | 1.85% | 1.50% | 1.26% |
| Average Diluted Shares Outstanding | 2.71% | 2.27% | 1.85% | 1.50% | 1.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |